Background
The combined effect of cardiorespiratory fitness (CRF) and body mass index (BMI) on cardiovascular disease (CVD) risk in young people remains to be fully determined. We examined the individual and combined associations of CRF and BMI with clustered CVD risk factors, and the mediator role of BMI in the association between CRF and clustered CVD risk factors in children and adolescents.
Methods
237 children (111 girls) and 260 adolescents (120 girls) were included in this cross‐sectional study. Height and weight were assessed and BMI was calculated. A CVD risk factor index (CVDRF‐I) was computed from: waist circumference, systolic blood pressure, triglycerides, high‐density lipoprotein cholesterol and glucose. CRF was assessed using the 20‐m shuttle run test. Regression analysis, analysis of covariance and mediation analysis (Baron and Kenny procedures) were used to test the independent and combined effect of CRF and BMI on CVDRF‐I, and to test mediation hypothesis, respectively.
Results
CRF was negatively associated with CVDRF‐I (all P < 0.05); however, after adjusting for BMI the associations were no longer significant in children and adolescents of both sex groups. Contrary, the association between BMI and CVDRF‐I was independent of CRF (all P < 0.001). The effect of CRF on CVDRF‐I was mediated by BMI. The percentage of the total effect of CRF on CVDRF‐I mediated by BMI for boys and girls children and boys and girls adolescents were 79.5%, 100%, 81.2% and 55.7%, respectively.
Conclusions
BMI is an independent predictor of CVDRF‐I and a mediator of the association between CRF and CVDRF‐I in children and adolescents. These results help to clarify the associations between CRF, weight status and cardiovascular health, suggesting that future CVD health would benefit from maintaining an optimal weight status.
Physical fitness was negatively associated with single and clustered inflammatory biomarkers, independently of body mass index. Increasing physical fitness levels in youth might contribute to reduce the cardiovascular risk.
Background:The main objective of this study was to describe the inflammatory status of adolescents with Down Syndrome (DS) and their relationship with fatness. Methods: 95DS adolescents (44.2% girls) and a control group of 113 adolescents (47.8% girls), 11-18 years, from the UP&DOWN Study participated. Serum C-reactive protein (CRP), C3 and C4 complement factors, total proteins, interleukin-6 (IL-6), tumor necrosis factor-α (TFN-α), insulin, cortisol, leptin, adiponectin, galactin-3 and visfatin were analyzed; HOMA-index was calculated. Body fat indicators: weight, height, waist circumference and skinfold thicknesses were measured. Birth weight was obtained by questionnaire. BMI, waist-to-height-ratio (WHtR) and body fat percentage (BF%) were calculated. Results: DS group showed higher levels of BMI, WHtR, waist circumference, BF%, and lower birth weight than controls (p<0.001). In the general lineal model in the total sample, WHtR was positively associated with C3 and C4 (p<0.001) as well as with leptin levels (p=0.015). BF% was positively associated with total proteins (p=0.093) and leptin levels (p<0.001). DS was positively associated with total proteins (p<0.001), C3 (p=0.047) and C4 (p=0.019). Despite the higher levels of fatness found in DS group, no direct association was found between BF% and leptin levels, opposite to the control group. Conclusions: these findings suggest that abdominal obesity should be controlled in adolescents due to its relationship with acute phase-inflammatory biomarkers, but especially on DS adolescents who may show a peculiar metabolic status according to their relationship between fatness and inflammatory biomarkers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.